在自身免疫性肝炎中,Mycophenolate Mofetil 与 Azathioprine 的有效性比较:系统性审查和元分析
Digestion
|August 28, 2025
概括
在自身免疫性肝炎 (AIH) 中,mycophenolate mofetil (MMF) 的完整生化反应 (CBR) 与阿扎西奥普林 (AZA) 相比有所改善. 这一发现在老年患者和IgG水平较低的患者中尤为显著,这表明MMF是一种有前途的替代治疗方法.
科学领域:
- 肝病学
- 免疫学
- 药理学
背景情况:
- 阿扎西奥普林 (AZA) 是自身免疫性肝炎 (AIH) 的标准治疗方法,但通常需要终身使用,并且有耐受性问题.
- 在AZA停止后,高复发率需要探索替代疗法.
- 结合使用普得尼索隆和AZA的疗法在疗效和安全性方面存在挑战.
研究的目的:
- 系统地审查和比较mycophenolate mofetil (MMF) 与AZA在治疗AIH中的疗效和安全性.
- 在接受MMF或AZA的患者中评估治疗结果,包括完整的生化反应 (CBR) 和类固醇戒断.
- 根据年龄和IgG水平分析子组影响.
主要方法:
- 随机临床试验和队列研究的系统审查和元分析.
- 搜索了主要的数据库:PubMed,Cochrane,Scopus和科学网络.
- 包括505名AIH患者的四项研究 (一项RCT,三项队列研究).
- 根据年龄 (>50岁) 和IgG水平 (<2400 mg/dL) 进行分组分析.
主要成果:
- 与阿扎西奥普林 (AZA) 相比,mycophenolate mofetil (MMF) 与完全生化反应 (CBR) 的增加有显著关联 (RR = 1.44, p=0. 03).
- 没有观察到MMF和AZA在类固醇戒断方面的显著差异.
- 在50岁以上的患者和IgG水平<2400 mg/ dL的患者中,MMF显示CBR增加.
结论:
- 在自身免疫性肝炎患者中,mycophenolate mofetil (MMF) 的完整生化反应 (CBR) 与阿扎西奥普林 (AZA) 相比较优异.
- 在特定的患者小组中,MMF提供了AZA的潜在有效替代品.
- 需要进一步的研究来确定不同人群的最佳AIH治疗策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201


